| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant therapy in stage IIIA melanoma
|
Hindié, Elif
|
|
|
22 |
7 |
p. e299
|
artikel
|
| 2 |
Adjuvant therapy in stage IIIA melanoma - Authors' reply
|
Eggermont, Alexander M M
|
|
|
22 |
7 |
p. e300
|
artikel
|
| 3 |
2021 ASCO Virtual Annual Meeting
|
Costa, Márcia
|
|
|
22 |
7 |
p. 912-913
|
artikel
|
| 4 |
A step closer to a personalised approach for Lynch syndrome
|
Ballester, Veroushka
|
|
|
22 |
7 |
p. 899-901
|
artikel
|
| 5 |
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
|
Pujade-Lauraine, Eric
|
|
|
22 |
7 |
p. 1034-1046
|
artikel
|
| 6 |
Biomedicine and the soul of medicine: optimising the balance
|
Rodin, Gary
|
|
|
22 |
7 |
p. 907-909
|
artikel
|
| 7 |
Calls to scale up international funding for tobacco control
|
Burki, Talha Khan
|
|
|
22 |
7 |
p. 911
|
artikel
|
| 8 |
CAR T-cell therapy for solid tumours
|
The Lancet Oncology,
|
|
|
22 |
7 |
p. 893
|
artikel
|
| 9 |
Chemoimmunotherapy in urothelial cancer: concurrent or sequential?
|
Zengin, Zeynep B
|
|
|
22 |
7 |
p. 894-896
|
artikel
|
| 10 |
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
|
Cardoso, Rafael
|
|
|
22 |
7 |
p. 1002-1013
|
artikel
|
| 11 |
Colorectal cancer screening in Europe: what are the next steps?
|
Gogenur, Ismail
|
|
|
22 |
7 |
p. 898-899
|
artikel
|
| 12 |
Endocrinopathies induced by immune checkpoint inhibitors: the need for clear endocrine diagnosis
|
Percik, Ruth
|
|
|
22 |
7 |
p. 905-907
|
artikel
|
| 13 |
Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer
|
Franzoi, Maria Alice
|
|
|
22 |
7 |
p. e303-e313
|
artikel
|
| 14 |
Gauging the quality-of-life benefits of immunotherapy in hepatocellular carcinoma
|
Personeni, Nicola
|
|
|
22 |
7 |
p. 896-898
|
artikel
|
| 15 |
Greater price transparency needed for thyroid cancer treatment among US cancer centres
|
Nierengarten, Mary Beth
|
|
|
22 |
7 |
p. 914
|
artikel
|
| 16 |
Immunotherapy in ovarian cancer: we are not there yet
|
Barber, Emma
|
|
|
22 |
7 |
p. 903-905
|
artikel
|
| 17 |
Impact of COVID-19 on cancer care in India: a cohort study
|
Ranganathan, Priya
|
|
|
22 |
7 |
p. 970-976
|
artikel
|
| 18 |
Intensifying neoadjuvant treatment in locally advanced rectal cancer
|
Patel, Swapnil
|
|
|
22 |
7 |
p. e301
|
artikel
|
| 19 |
Intensifying neoadjuvant treatment in locally advanced rectal cancer – Authors' reply
|
Conroy, Thierry
|
|
|
22 |
7 |
p. e302
|
artikel
|
| 20 |
Is complete mesocolic excision superior to conventional colectomy for colon cancer?
|
Miskovic, Danilo
|
|
|
22 |
7 |
p. 917-918
|
artikel
|
| 21 |
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
|
Lee, Chung-Han
|
|
|
22 |
7 |
p. 946-958
|
artikel
|
| 22 |
Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial
|
Kaidar-Person, Orit
|
|
|
22 |
7 |
p. e294
|
artikel
|
| 23 |
Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial
|
Marta, Gustavo Nader
|
|
|
22 |
7 |
p. e297
|
artikel
|
| 24 |
Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial
|
Vaidya, Jayant S
|
|
|
22 |
7 |
p. e295-e296
|
artikel
|
| 25 |
Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial
|
Fastner, Gerd
|
|
|
22 |
7 |
p. e293
|
artikel
|
| 26 |
Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial – Authors' reply
|
Orecchia, Roberto
|
|
|
22 |
7 |
p. e298
|
artikel
|
| 27 |
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
|
Galle, Peter R
|
|
|
22 |
7 |
p. 991-1001
|
artikel
|
| 28 |
Patient selection for immunotherapy in head and neck cancer
|
Bonomo, Pierluigi
|
|
|
22 |
7 |
p. e290
|
artikel
|
| 29 |
Patient selection for immunotherapy in head and neck cancer – Authors' reply
|
Lee, Nancy Y
|
|
|
22 |
7 |
p. e291-e292
|
artikel
|
| 30 |
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
|
Powles, Thomas
|
|
|
22 |
7 |
p. 931-945
|
artikel
|
| 31 |
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
|
Balar, Arjun V
|
|
|
22 |
7 |
p. 919-930
|
artikel
|
| 32 |
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
|
Gainor, Justin F
|
|
|
22 |
7 |
p. 959-969
|
artikel
|
| 33 |
Real-time fluorescence imaging for cancer surgery: a pathologist's perspective
|
Sarode, Sachin C
|
|
|
22 |
7 |
p. e282
|
artikel
|
| 34 |
Real-time fluorescence imaging for cancer surgery: a pathologist's perspective – Authors' reply
|
Lauwerends, Lorraine J
|
|
|
22 |
7 |
p. e283
|
artikel
|
| 35 |
Richter's transformation in the heart
|
Marra, Andrea
|
|
|
22 |
7 |
p. e341
|
artikel
|
| 36 |
Second-line FOLFOX chemotherapy for advanced biliary tract cancer
|
Wei, Fangqiang
|
|
|
22 |
7 |
p. e284
|
artikel
|
| 37 |
Second-line FOLFOX chemotherapy for advanced biliary tract cancer
|
Foo, Tiffany
|
|
|
22 |
7 |
p. e286
|
artikel
|
| 38 |
Second-line FOLFOX chemotherapy for advanced biliary tract cancer
|
Pramanik, Raja
|
|
|
22 |
7 |
p. e287
|
artikel
|
| 39 |
Second-line FOLFOX chemotherapy for advanced biliary tract cancer
|
Brandi, Giovanni
|
|
|
22 |
7 |
p. e285
|
artikel
|
| 40 |
Second-line FOLFOX chemotherapy for advanced biliary tract cancer – Authors' reply
|
Lamarca, Angela
|
|
|
22 |
7 |
p. e288-e289
|
artikel
|
| 41 |
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
|
Ren, Zhenggang
|
|
|
22 |
7 |
p. 977-990
|
artikel
|
| 42 |
Spinal stereotactic radiotherapy for painful spinal metastasis
|
van der Velden, Joanne M
|
|
|
22 |
7 |
p. 901-903
|
artikel
|
| 43 |
Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial
|
Sahgal, Arjun
|
|
|
22 |
7 |
p. 1023-1033
|
artikel
|
| 44 |
The concept and use of the neoadjuvant rectal score as a composite endpoint in rectal cancer
|
Glynne-Jones, Robert
|
|
|
22 |
7 |
p. e314-e326
|
artikel
|
| 45 |
The Dietary Supplement Health And Education Act: are we healthier and better informed after 27 years?
|
Sissung, Tristan M
|
|
|
22 |
7 |
p. 915-916
|
artikel
|
| 46 |
UK Government urged to recognise post-COVID-19 cancer backlog
|
Wilkinson, Emma
|
|
|
22 |
7 |
p. 910
|
artikel
|
| 47 |
Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)
|
Biganzoli, Laura
|
|
|
22 |
7 |
p. e327-e340
|
artikel
|
| 48 |
Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study
|
|
|
|
22 |
7 |
p. 1014-1022
|
artikel
|
Tijdschrift beschrijving